Rawla P. Epidemiology of prostate Cancer. World J Oncol. 2019;10(2):63–89.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jang A, Sartor O, Barata PC, Paller CJ. Therapeutic potential of PARP inhibitors in the treatment of metastatic castration-resistant prostate Cancer. Cancers (Basel). 2020;12(11).

Mehtala J, Zong J, Vassilev Z, Brobert G, Gabarro MS, Stattin P, et al. Overall survival and second primary malignancies in men with metastatic prostate cancer. PLoS ONE. 2020;15(2):e0227552.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Rizzo M. Mechanisms of docetaxel resistance in prostate cancer: the key role played by miRNAs. Biochim Biophys Acta Rev Cancer. 2021;1875(1):188481.

Article  CAS  PubMed  Google Scholar 

Guerrero-Ochoa P, Rodriguez-Zapater S, Anel A, Esteban LM, Camon-Fernandez A, Espilez-Ortiz R et al. Prostate Cancer and the Mevalonate Pathway. Int J Mol Sci. 2024;25(4).

Allott EH, Farnan L, Steck SE, Arab L, Su LJ, Mishel M, et al. Statin use and prostate Cancer aggressiveness: results from the Population-based North Carolina-Louisiana prostate Cancer Project. Cancer Epidemiol Biomarkers Prev. 2016;25(4):670–7.

Article  CAS  PubMed  Google Scholar 

Iannelli F, Roca MS, Lombardi R, Ciardiello C, Grumetti L, De Rienzo S, et al. Synergistic antitumor interaction of valproic acid and simvastatin sensitizes prostate cancer to docetaxel by targeting CSCs compartment via YAP inhibition. J Exp Clin Cancer Res. 2020;39(1):213.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Weichert W, Roske A, Gekeler V, Beckers T, Stephan C, Jung K, et al. Histone deacetylases 1, 2 and 3 are highly expressed in prostate cancer and HDAC2 expression is associated with shorter PSA relapse time after radical prostatectomy. Br J Cancer. 2008;98(3):604–10.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bruzzese F, Pucci B, Milone MR, Ciardiello C, Franco R, Chianese MI, et al. Panobinostat synergizes with zoledronic acid in prostate cancer and multiple myeloma models by increasing ROS and modulating mevalonate and p38-MAPK pathways. Cell Death Dis. 2013;4(10):e878.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ashburn TT, Thor KB. Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov. 2004;3(8):673–83.

Article  CAS  PubMed  Google Scholar 

Salem O, Hansen CG. The Hippo pathway in prostate Cancer. Cells. 2019;8(4).

Liu X, Chinello C, Musante L, Cazzaniga M, Tataruch D, Calzaferri G, et al. Intraluminal proteome and peptidome of human urinary extracellular vesicles. Proteom Clin Appl. 2015;9(5–6):568–73.

Article  CAS  Google Scholar 

Silva JC, Gorenstein MV, Li GZ, Vissers JP, Geromanos SJ. Absolute quantification of proteins by LCMSE: a virtue of parallel MS acquisition. Mol Cell Proteom. 2006;5(1):144–56.

Article  CAS  Google Scholar 

Tyanova S, Temu T, Sinitcyn P, Carlson A, Hein MY, Geiger T, et al. The Perseus computational platform for comprehensive analysis of (prote)omics data. Nat Methods. 2016;13(9):731–40.

Article  CAS  PubMed  Google Scholar 

Lombardi R, Sonego M, Pucci B, Addi L, Iannelli F, Capone F, et al. HSP90 identified by a proteomic approach as druggable target to reverse platinum resistance in ovarian cancer. Mol Oncol. 2021;15(4):1005–23.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009;4(1):44–57.

Article  PubMed  Google Scholar 

Raudvere U, Kolberg L, Kuzmin I, Arak T, Adler P, Peterson H, et al. G:profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update). Nucleic Acids Res. 2019;47(W1):W191–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Pang Z, Chong J, Zhou G, de Lima Morais DA, Chang L, Barrette M, et al. MetaboAnalyst 5.0: narrowing the gap between raw spectra and functional insights. Nucleic Acids Res. 2021;49(W1):W388–96.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu T, Mendes DE, Berkman CE. Prolonged androgen deprivation leads to overexpression of calpain 2: implications for prostate cancer progression. Int J Oncol. 2014;44(2):467–72.

Article  CAS  PubMed  Google Scholar 

Li J, Xu X, Jiang Y, Hansbro NG, Hansbro PM, Xu J, et al. Elastin is a key factor of tumor development in colorectal cancer. BMC Cancer. 2020;20(1):217.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gong Y, Chippada-Venkata UD, Oh WK. Roles of matrix metalloproteinases and their natural inhibitors in prostate cancer progression. Cancers (Basel). 2014;6(3):1298–327.

Article  PubMed  Google Scholar 

Zhang G, Miyake M, Lawton A, Goodison S, Rosser CJ. Matrix metalloproteinase-10 promotes tumor progression through regulation of angiogenic and apoptotic pathways in cervical tumors. BMC Cancer. 2014;14:310.

Article  PubMed  PubMed Central  Google Scholar 

Ozden F, Saygin C, Uzunaslan D, Onal B, Durak H, Aki H. Expression of MMP-1, MMP-9 and TIMP-2 in prostate carcinoma and their influence on prognosis and survival. J Cancer Res Clin Oncol. 2013;139(8):1373–82.

Article  CAS  PubMed  Google Scholar 

Zhang Y, Xi S, Chen J, Zhou D, Gao H, Zhou Z, et al. Overexpression of LAMC1 predicts poor prognosis and enhances tumor cell invasion and migration in hepatocellular carcinoma. J Cancer. 2017;8(15):2992–3000.

Article  PubMed  PubMed Central  Google Scholar 

Cattrini C, Barboro P, Rubagotti A, Zinoli L, Zanardi E, Capaia M, et al. Integrative Analysis of Periostin in primary and advanced prostate Cancer. Transl Oncol. 2020;13(7):100789.

Article  PubMed  PubMed Central  Google Scholar 

Hu Q, Tong S, Zhao X, Ding W, Gou Y, Xu K, et al. Periostin mediates TGF-beta-Induced epithelial mesenchymal transition in prostate Cancer cells. Cell Physiol Biochem. 2015;36(2):799–809.

Article  CAS  PubMed  Google Scholar 

Dong Q, Fu L, Zhao Y, Du Y, Li Q, Qiu X, et al. Rab11a promotes proliferation and invasion through regulation of YAP in non-small cell lung cancer. Oncotarget. 2017;8(17):27800–11.

Article  PubMed  PubMed Central  Google Scholar 

Dupont S, Morsut L, Aragona M, Enzo E, Giulitti S, Cordenonsi M, et al. Role of YAP/TAZ in mechanotransduction. Nature. 2011;474(7350):179–83.

Article  CAS  PubMed  Google Scholar 

Costello LC, Franklin RB. The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots. Mol Cancer. 2006;5:17.

Article  PubMed  PubMed Central  Google Scholar 

Fabregat A, Sidiropoulos K, Viteri G, Forner O, Marin-Garcia P, Arnau V, et al. Reactome pathway analysis: a high-performance in-memory approach. BMC Bioinformatics. 2017;18(1):142.

Article  PubMed  PubMed Central  Google Scholar 

You X, Tian J, Zhang H, Guo Y, Yang J, Zhu C, et al. Loss of mitochondrial aconitase promotes colorectal cancer progression via SCD1-mediated lipid remodeling. Mol Metab. 2021;48:101203.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Sajnani K, Islam F, Smith RA, Gopalan V, Lam AK. Genetic alterations in Krebs cycle and its impact on cancer pathogenesis. Biochimie. 2017;135:164–72.

Article  CAS  PubMed  G